SB477
Interim Study (Senate)relative to increasing transparency in the 340B Drug Pricing Program.
Senate
Health and Human Services
2026 Session
Status
Introduced
Senate Committee
Senate Vote
House
House Vote
Governor
Interim Study (Senate)
Hearing
No upcoming hearing scheduled.
Testimony
Support
32
Oppose
63
95 total submissions
Bill Docket
Refer to Interim Study, MA, VV; 03/05/2026; SJ 5
SenateMarch 05, 2026
Committee Report: Referred to Interim Study, 03/05/2026, Vote 5-0; SC 8
SenateFebruary 19, 2026
Special Order to the Next Session, Without Objection, MA; 02/19/2026; SJ 4
SenateFebruary 19, 2026
SB 477 was Removed from the Consent Calendar; 02/19/2026; SJ 4
SenateFebruary 19, 2026
Committee Report: Referred to Interim Study, 02/19/2026; Vote 5-0; CC; SC 6
SenateFebruary 12, 2026
Hearing: 01/21/2026, Room 100, SH, 01:30 pm; SC 2
SenateJanuary 12, 2026
Introduced 01/07/2026 and Referred to Health and Human Services; SJ 1
SenateNovember 21, 2025
Bill Text (Introduced)
Loading bill text...